Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

被引：42

作者：

Vasquez, JC ^{[1
]}

Vichiendilokkul, A ^{[1
]}

Mahmood, S ^{[1
]}

Baciewicz, FA ^{[1
]}

机构：

[1] Harper Univ Hosp, Dept Cardiothorac Surg, Detroit, MI 48201 USA

来源：

ANNALS OF THORACIC SURGERY | 2002年 / 74卷 / 06期

关键词：

D O I：

10.1016/S0003-4975(02)04125-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heparin is the standard agent used for systemic anticoagulation during cardiopulmonary bypass in cardiac operations. Alternatives are needed when patients with heparin-induced thrombocytopenia type II are encountered. We present a patient with a clinical picture of heparin-induced thrombocytopenia type II who was effectively anticoagulated with bivalirudin, a direct thrombin inhibitor, during cardiopulmonary bypass for a cardiac operation.

引用

页码：2177 / 2179

页数：3

共 5 条

[1] Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia [J].

Aouifi, A ;

Blanc, P ;

Piriou, V ;

Bastien, OH ;

Ffrench, P ;

Hanss, M ;

Lehot, JJ .

ANNALS OF THORACIC SURGERY, 2001, 71 (02) :678-683

[2] Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study [J].

Bittl, JA ;

Chaitman, BR ;

Feit, F ;

Kimball, W ;

Topol, EJ .

AMERICAN HEART JOURNAL, 2001, 142 (06) :952-959

[3] Heparin-induced thrombocytopenia [J].

Brieger, DB ;

Mak, KH ;

Kottke-Marchant, K ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1449-1459

[4] The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations [J].

Furukawa, K ;

Ohteki, H ;

Hirahara, K ;

Narita, Y ;

Koga, S .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06) :1255-1256

[5]

Sciulli TM, 2002, ANN PHARMACOTHER, V36, P1028

← 1 →